MGCLY · Verdict

A summary of rules, not a profit forecast — don’t buy just because of a green verdict.

• ▲ P/E 13.5 vs peer median 24.7 — cheaper than peers
• ▲ P/S 1.4 vs peer median 1.9 — cheaper than peers
• ▼ FCF yield 6.8% vs peer median 5.1% — more expensive than peers

• ▼ Share count up 12% in 3 y — your stake is being diluted
• ▲ Piotroski 7/9 — strong financial health
• ▲ ROE 20% — high return on equity
• ▲ Net margin rose: 8.5% → 9.6%
• ▲ Debt / equity 0.30 — moderate debt
• ▲ Free cash flow positive every year

• ▲ Revenue grows 9.9% per year (3 y)
• ▲ Earnings per share grows 10.0% per year (3 y)

• ▲ Over 6 mo stronger than its sector (XLY) by 8%
• ▲ Price above SMA200 — long-term uptrend
• ▲ SMA50 above SMA200 — trend up

• ▼ Volatility 29% per year — much higher than the market (13%)

• ▲ S&P 500 above SMA200 — the market is in an uptrend
• ▼ Sector (XLY) below SMA200 — in a downtrend